Suvorexant 67651-0385
Product NDC
67651-0385- Manufacturer
- Patheon Pharmaceuticals Inc.
- Dosage Form
- Tablet, Film Coated
- Product Type
- Drug For Further Processing
- DEA Schedule
- Schedule CIV
- Marketing Start
- January 20, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Suvorexant | 20 mg/1 |
Packaging Options(1)
116000 TABLET, FILM COATED in 1 DRUM (67651-0385-0)